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Chloroacetyl Tyrosine in Incomplete Freund's Adjuvant*
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Many studies ofspecific T-cell tolerance involvingthe use ofsmall well-defined
contact allergens are complicated by the unknown role of autologous protein
determinants resulting from in situ conjugation (1-4) . Similarly, the multiplicity
ofdeterminants present during tolerance induction with foreign proteins hinders
suitable analysis of the roles played by different determinants and degradation
products that may interact with T-cell subclasses during tolerance induction
(5-7). It seemed, therefore, advantageous to develop an experimental model
permitting induction of stable T-cell tolerance to a small, well-characterized
T-cell immunogen. Forthis we have selected the low molecular weight compound
azobenzenearsonate (ABA)1 conjugated to N-chloroacetyl tyrosine (ABA-T) and
various protein conjugates of this compound . ABA-T and similar derivatives
have already proven useful in analysis of hapten-carrier requirements during
induction of delayed immunity (8-10), T-cell helper function (11-13), and
specific immunological tolerance in newborn (14) and adult guinea pigs (15, 16).
In the latter case, however, tolerance induction was of short duration and
required substantial amounts of antigen (15, 16).
Previous work in our laboratory has demonstrated that B cells can be optimally
tolerized by large doses of polyvalent nonimmunogenic molecules such as
dinitrophenyl (DNP) conjugates of the copolymer D-glutamic acid D-lysine
(DNP-D-GL) (reviewed in 17 and 18). In contrast, T cells involved in delayed
hypersensitivity reactions cannot be tolerized by such molecules since neither
*This investigationwas supported by grants AI-10630 and AI-09920 from the U. S. Public Health
Service, National Institutes of Health, Bethesda, Md.
fRecipient of a fellowship from the Helen Hay Whitney Foundation.
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DNP-D-GL nor ABA-D-GL in large amounts could block delayed hypersensitivity
to dinitrochlorobenzene or ABA-T, respectively (reference 19 and footnote 2) . It
was therefore suggested that acquired T-cell tolerance may be an active process
which should be inducible with "immunogenic doses" of tolerogen administered
under non-immunogenic conditions. 2
The experiments presented in this paper demonstrate that the induction of
tolerance on the one hand and the induction of delayed sensitivity on the other
hand can be accomplished by administration of similar doses of ABA-T to guinea
pigs with the determining factor being the absence or presence, respectively, of
activating bacterial products in the adjuvant mixture used. Thus, complete,
persistent ABA-T-specific T-cell tolerance can be induced in adult guinea pigs
with 20 gg of ABA-T given intradermally in incompleteFreund's adjuvant (IFA),
whereas this same dose of ABA-T induces ABA-specific immunity when
administered in complete Freund's adjuvant (CFA). This tolerance was not
reversible by administration of ABA-T and IFA in the presence of bacterial
lipopolysaccharide (LPS), was generated before the formation of primed T cells,
and persisted for at least 3 mo after initiation .
Materials and Methods
Proteins and Chemical Reagents.
￿
Bovine serum albumin (BSA) and guinea pig albumin (GPA)
were purchased from Pentex Biochemical, Kankakee, Ill . Recrystallized bovine pancreatic insulin
(INS) was obtained from Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y. Human
7S gamma globulin (HGG), chloroacetyl-L-tyrosine, and tyramine hydrochloride were purchased from
Mann Research Labs., Inc ., Springfield, Mo. Escherichia coli LPS (055:135) was obtained from Difco
Laboratories, Inc., Detroit, Mich. (lot no. 585002) .
Antigens
PREPARATION OF MONO(p-AZOBENZENEARSONIC ACID) -N-CHLOROACETYL-L-TYROSINE (ABA-T).
￿
500 mg
p-aminobenzenearsonic acid in 20 ml distilled H,O was dissolved by addition of 3 ml of 1N HCI,
placed on ice and then 3 ml of 5% NaNO, was added to form the diazonium salt. 1 g of
chloroacetyl-L-tyrosine was dissolved in 20 ml of5% Na,CO, and the pH adjusted to 9 with 1N NaOH.
The cold diazonium salt of arsanilate was slowly added to the chloroacetyl-L-tyrosine solution and the
mixture stirred at room temperature for 2 h maintaining the pH at 9 with 1N NaOH. The ABA-T
product was precipitated by acidification with 1N HCl and washed. The compound was redissolved
and reprecipitated twice from water by bringing the pH to 9 and then acidifying slowly. The
concentration of ABA-T was determined spectrophotometrically using E, cm - 10,500 at 490 nm in 0.1
N NaOH (20, 21) .
PREPARATION OF ABA-PROTEIN CONJUGATES. Proteins were reacted with the diazonium salt of
arsanilate for 3 h at room temperature using ratios of 1:2 or 1:6 (milligrams arsanilate:milligrams
protein) for high and low substitutions, respectively. The resulting conjugates were dialyzed
extensively against phosphate-buffered saline (PBS) at 4°C. Final protein concentrations were
determined by micro-Kjeldahl analysis (22), and the degree of ABA substitution of tyrosine residues
was determined spectrophotometrically. Since ABA-lysine does not absorb at 490 nm (21), it was
assumed that the degree of lysine substitution did not significantly affect these calculations. The
ABA molar substitution ratios were: ABA,,-HGG, ABA,,-BSA, ABA.-GPA, and ABA,-INS.
Animals and Immunizations.
￿
Male Hartley and strain 13 guinea pigs, 300-600 g, were obtained
2 Bullock, W. W., D. H. Katz, and B. Benacerraf. 1975. Induction of T-lymphocyte responses to a
small molecular weight antigen. I. Failure to induce tolerance in azobenzenearsonate (ABA)-specific
T cells in guinea pigs with ABA conjugate of a copolymer of D-glutamic acid and D-lysine. J. Immunol.
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from Camm Research Institute, Inc., Wayne, N. J. Antigens were dissolved in 0.15 M NaCl and
emulsified with an equal volume of either CFA or IFA (Difco Laboratories, Inc.). For CFA
immunization of strain 13 guinea pigs, IFAwas mixed with Mycobacterium tuberculosis H37RV (2.5-
5.0 mg/ml). For immunization, 0.4 ml was equally distributed into the four foot pads or at four intra-
dermal neck sites.
Skin Testing.
￿
Animals were shaved along each side and tested at one to four sites. Intradermal
injections consisted of 10 or 50 Ag of antigen given in 0.1 ml of saline. Reactions were read at 3, 24, and
48 h. The diameter (millimeters) of the erythema and degree of induration were recorded at 24 and
48 h.
Statistical Analysis.
￿
Means and standard errors of the diameters of delayed hypersensitivity
reactions of the various experimental groups were calculated arithmetically and group comparisons
were made employing Student's t test.
Results
Determination of Optimal Immunogenic Dose Range of ABA-T in Random
Bred and Inbred Guinea Pigs. Groups ofrandom bred Hartley guinea pigs were
immunized with log incremental doses of ABA-T in CFA (2-2,000 Ag/animal) or
with CFA alone. 2 wk later all animals were skin tested with ABA-HGG and
purified protein derivative oftuberculin (PPD). As shown in Table I, doses of 20
TABLE I
Dose Response for Induction of Delayed Sensitivity with ABA-T Administered in CFA
* Hartley guinea pigs were immunized with log incremental doses of ABA-T administered in CFA in
the foot pads. 2 wk later, these animals were skin tested with ABA-HGG and PPD.
$ Skin tests were performed on individual animals in each group using 50,ug ABA-HGG and 10 lug
PPD. The data are presented as the average reaction diameters in millimeters of groups of four
guinea pigs recorded 24 h after intradermal sensitization . Numbers in parentheses are standard
errors.
and 200 )ug of ABA-T were optimal for eliciting ABA-specific T-cell immunity;
the 2 leg dose of the range tested (2-2,000 jig) was clearly less effective.
Immunization with CFA alone failed, as expected, to induce sensitivity to
ABA-T, although good sensitivity to PPD was obtained in this group. Studies
with inbred strain 13 guinea pigs demonstrated comparable responses with the
optimal doses, provided that H37RV Mycobacterium was used in the CFA.
Induction of Transient ABA-Specific Tolerance in Guinea Pigs after Intrave-
nous Administration of ABA-T. In previous studies of Leskowitz and Collotti
(15, 16), ABA-specific tolerance was induced by intracardiac or intraperitoneal
administration of aqueous ABA-T before sensitization with immunogenic quan-
tities of ABA-T in CFA. The data presented in Table II summarizes our own
Group
Protocol*
Immunization (wk0)
Delayed skin
ABA-HGG (50mg, wk 2)
MM
reactions$
PPD (10ug, wk 2)
mm
A Saline (CFA) 4.0 (=0.4) 23.2 (=0.9)
B 2Ag ABA-T (CFA) 6.0 (=0.7) 23.7 (=1.0)
C 201+g ABA-T (CFA) 19.5 (=0.6) 24.0 (=0.6)
D 200,ug ABA-T(CFA) 26.3 (=3.3) 22.5 (=1.6)
E 2*000Kg ABA-T(CFA) 19.0 (=1.6) 22.2 (11.0)264
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TABLE II
Induction of Transient ABA-Specific Tolerance in Guinea Pigs after Intravenous
Administration of ABA-T
* Hartley guinea pigs were pretreated with 2.0 mg ABA-T administered intravenously (group B) . 30
min later this group plus an additional group were sensitized with 50 ug ABA-T in CFA in thefoot
pads. All animals plus a group of unsensitized controls were skin tested at 3 wk and 7 wk after
immunization with ABA-BSA and ABA-HGG, respectively.
$Skin tests were performed on individual animals in each group using 50 kg of the test antigen
indicated. The data are presented as the averagereaction diameters in millimeters of groups of five
guinea pigs recorded 24 h after intradermal sensitization. Allunsensitized control reactionswere <2
mm. Numbers in parentheses are standard errors. Statistical analysis of mean delayed skin
reactionsyielded Pvalues of <0.001 at 3 wk and >0.2 at 7wk forgroup Bcompared to groupA.
experience with such attempts at tolerance induction in this system. Guinea pigs
were injected intravenously with either 2.0 mg of aqueous ABA-T or, as controls,
with saline and then immunized with 50 ug of ABA-T in CFA immediately
thereafter. Skin tests performed with ABA-BSA 3 wk after sensitization
revealed a substantial suppression of ABA-specific delayed hypersensitivity in
the group pretreated with intravenous ABA-T as compared to controls. The PPD
responses were equivalent in the two groups (not shown) . The suppression of
ABA-specific responses in this system was only transient, however, since by wk 7
after sensitization, the level of ABA-specific delayed hypersensitivity was
essentially indistinguishable between the treated and untreated groups.
Suppression of ABA-Specific T-Cell Responses by Administration ofImmuno-
genic Doses of ABA-T in IFA. In the preceding experiment it was shown that
intravenous administration of ABA-T induced a transient state of specific
unresponsiveness . The transient nature of the unresponsiveness induced in this
manner is perhaps not surprising in view of the previous demonstration by
Leskowitz that 95% of the ABA-T is excreted within 5 days after intravenous
injection (15). In order to analyze the mechanism(s) underlying T-cell tolerance,
we felt that a regimen for inducing tolerance of longer duration with a
moderate-to-low dose of ABA-T would be desirable. This was accomplished by
administering ABA-T as a depot in IFA emulsions.
As shown in Fig. 1, groups of Hartley guinea pigs were injected with log
incremental doses (2-200 lug) of ABA-T in IFA in the foot pads, and 1 wk
thereafter these animals and a group ofuntreated controls were immunized with
50 ug ofABA-T in CFA intracutaneously. 4wk later all animals were skin tested
with ABA-HGG and PPD. The guinea pigs injected with ABA-T in IFA were in
all instances suppressed in responsiveness to ABA-T as compared to untreated
Group Pretreatment (wk
Protocol*
0) Immunization
Delayed
ABA-BSA
(50Mg,wk 3)
MM
skin reactions$
ABA-HGG
(50jig, wk 7)
mm
A None 50AgABA-T(CFA) 16.6 (t5.2) 14.7 (f2.7)
B 2.0 mg ABA-T 50 Ag ABA-T(CFA) 2.6 (t0.2) 10.5 (t2.0)
intravenouslyWESLEY W. BULLOCK, DAVID H . KATZ, AND BARUJ BENACERRAF
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FIG. 1 .
￿
Hartley guinea pigs were pretreated with log incremental doses (2-200 ug) of ABA-T
in IFA in the foot pads. 1 wk later these animals and a group of untreated controls were
intracutaneously immunized with 50 jug of ABA-T in CFA . 4 wk later all animals were skin
tested with 50 jig of ABA-HGG and 10 jug of PPD. The data are presented as the average
reaction diameters in millimeters of groups of six guinea pigs each recorded 24 h after
intradermal sensitization . The vertical lines represent standard errors . The dashed line
represents the mean reaction diameter of nonsensitized controlguinea pigs skin tested with the
same preparation of ABA-HGG at the same time . Statistical comparisons of the mean skin
reactions to ABA-HGG of the pretreated groups with those of the untreated controls yielded
the following P values : P = 0.035 for the group pretreated with 2 ug, andP < 0.001 for the
groups pretreated with 20 and 200 pg .
controls . The optimal doses resulting in suppression were 20 and 200,ug but even
the lowest of 2 jug exerted a detectable suppressive effect . The unresponsiveness
was ABA-specific since the degree of PPD sensitivity was not diminished in any
of the pretreated animals (indeed, PPD reactivity was inversely related in
magnitude to ABA-specific responses) . Moreover, pretreatment with IFA alone
did not diminish responsiveness to subsequent immunization with ABA-T in
CFA (not shown) .
The suppressive effect of pretreatment with ABA-T in IFA appears to be
relatively persistent . In the experiment shown in Fig . 2, two groups of guinea pigs
were injected with 50 Ag of ABA-T in either CFA or IFA ; 2 wk later these
animals and a third group of untreated guinea pigs were skin tested with ABA-
HGG followed by intradermal immunization with ABA-T in CFA . As shown, it
is clear that only the group of guinea pigs sensitized initially with ABA-T in CFA
manifested ABA-specific delayed hypersensitivity at this point (wk 2) . A second
skin test performed with ABA-BSA 2 wk later (wk 4 of the experiment) revealed
positive ABA-specific reactions in all but the guinea pigs that had been initially
treated with ABA-T in IFA . The significant diminution at wk 4 in the magnitude
of responses in the group sensitized with ABA-T in CFA at the beginning of the
experiment and then immunized again with ABA-T in CFA at wk 2 may reflect
the use of the same mycobacterial adjuvant within a short interval, but, in fact, is
without a definitive explanation at this time . Even as late as 7 wk after
initiation of the experiment, guinea pgis pretreated with ABA-T in IFA were
significantly suppressed in their capacity to develop ABA-specific responses as266
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FIG . 2 .
￿
Guinea pigs were injected with 50 kg of ABA-T in eitherCFA or IFA ; 2 wk later these
animals and a third group of untreated guinea pigs were skin tested with ABA-HGG followed
by intradermal immunization with 50 lag of ABA-T in CFA . 2 wk later (wk 4 of the
experiment) animals were skin tested with 50 Ag ofABA-BSA . A third skin test was performed
with 50 mg of ABA-INS 7 wk after initiation of the experiment . The data are presented as the
average reaction diameters in millimeters of groups of three guinea pigs recorded 24 h after
intradermal sensitization . The vertical lines represent standard errors . The dashed lines
represent the mean reaction diameters ofnonsensitized control guinea pigs skin tested with the
same preparations of ABA-HGG, ABA-BSA, and ABA-INS at each time in the experiment .
Statistical comparisons of the mean skin reactions of the groups treated at the initiation of the
experiment with the untreated controls yielded the following P values at the various times of
skin tests : (a) wk 2, P < 0.001 in the case of ABA-T (CFA) andP > 0.90 in the case of ABA-T
(IFA) ; (6) wk 4, P = 0.007 in the case of ABA-T (CFA) and P < 0.001 in the case of ABA-T
(IFA) ; (c) wk 7, P > 0.90 in the case of ABA-T (CFA) and P = 0.004 in the case of ABA-T
(IFA) . Comparison ofthe reactions at wk 4 ofthe group initially sensitized with ABA-T inCFA
with those given ABA-T in IFA yielded P < 0.001 .
evidenced by a third skin test elicited with ABA-INS. Again, the suppression was
specific since PPD responses were not appreciably different between the groups
(not shown) . More recent experiments have shown this tolerance to persist for
greater than 3 mo .
The administration of ABA-T in IFA may exert a suppressive effect on either
the initial T-cell sensitization phase or block the elicitation of delayed skin
reactivity . In order to distinguish between these two possibilities, an experiment
was performed to determine whether or not treatment with ABA-T in IFA would
exert any suppressive effect in animals that had been previously sensitized with
ABA-T in CFA and then skin-tested 1 wk later with ABA-BSA. As shown in Fig .
3, two groups of guinea pigs so sensitized displayed ABA-specific delayed
responses 7 days later . At this time, one group was treated with intradermal
injections of ABA-T in IFA in an attempt to abrogate the sensitive state .
However, as shown by subsequent skin tests on days 18 and 31, no significant
depression of the ABA-specific delayed responses was obtained as a result of such
treatment . These data indicate, therefore, that previously sensitized T cells
cannot be rendered unresponsive by this regime, and also that the administration
of ABA-T in IFA does not inhibit elicitation of skin tests in appropriately
sensitized animals .WESLEY W . BULLOCK, DAVID H . KATZ, AND BARUJ BENACERRAF
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The Effects of LPS on the Suppressive Properties of ABA-TAdministered in
IFA. The potent tolerogenic'or suppressive effects of ABA-T administered in
IFA contrasts sharply with the very immunogenic properties of this antigen when
incorporated in complete adjuvant containing mycobacterial products . Since
previous studies in our laboratory (23-25) and others (26) have demonstrated
that LPS can exert marked adjuvant effects on T-lymphocyte functions, we
sought to determine whether incorporation of LPS into the IFA emulsion would
influence in any way the suppression phenomenon normally resulting from
administration of ABA-T in this manner . Groups of guinea pigs were injected
with 50 hg of ABA-T incorporated, respectively, into emulsions of IFA alone,
IFA containing 200 jig of LPS, CFA alone, and CFA containing 200 lAg of LPS .
Skin tests for ABA-specific delayed sensitivity responses 2 wk later again demon-
strated marked suppression in the group that had received ABA-T in IFA as
compared to guinea pigs sensitized with ABA-T in CFA (Table III) . More
significantly, the incorporation ofLPS into the IFA emulsion completely reversed
the tolerogenic properties and resulted in ABA-specific delayed responses that
were comparable to those obtained in animals immunized with ABA-T in CFA.
The addition of LPS to CFA had no appreciable influence on the magnitude of
ABA sensitivity elicited in this way . The capacity of LPS to convert ABA-T in
IFA to an immunogenic rather than tolerogenic emulsion was not merely a
transient effect since skin tests performed 5 wk later also revealed differences
comparable to those observed at 2 wk (data not shown) .
A final experiment was performed to determine whether the potent adjuvant
FiG . 3 .
￿
Two groups of animals were immunized with 50 kg ABA-T in CFA in the foot pads. 7
days later each group was skin tested with 50 gg ABA-BSA . 1 day later one group
intradermally received 50,ug ofABA-T in IFA; the second group was not treated . On days 18
and 31 after initial sensitization, both groups were again skin tested with 50 kg of either
ABA-INS or ABA-HGG . The data are presented as the average reaction diameters in
millimeters ofgroups of five guinea pigs recorded 24 h after intradermal sensitization . The ver-
tical lines represent standard errors. Statistical comparisons of the mean skin reactions of the
two groups yielded Pvalues of P > 0.20 or greater at each day tested .268
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TABLE III
The Effects of LPS on the Suppressive Properties of ABA-T
Administered in IFA
Protocol* Delayedskin
reactions$ with
* Hartley guinea pigs were injected in the foot pads with 50 kg ABA-T
either in IFAalone, IFAplus 200kg LPS, CFA alone, or CFAplus 200pg
LPS. 2 wk later all animals were skin tested with ABA-HGG.
$Skin tests were performed on individual animals in each group using50
Mg of ABA-HGG. The data are presented as the average reaction
diameters in millimeters of groups of three guinea pigs recorded 24 h
after intradermal sensitization. Numbers in parentheses are standard
errors. Statistical comparisons of the mean skin reactions to ABA-HGG
yielded P values of >0.15 comparing group B and D to C and <0.001
comparing group A to C.
influence ofLPS could be utilized to perhaps abrogate a previously induced state
of ABA-specific unresponsiveness. Two groups of guinea pigs were pretreated
with 50 leg ofABA-T in IFA. 3 wk laterthese animals andtwo groups ofuntreated
controls were sensitized, respectively, with 50 ug of ABA-T either in CFA or IFA
containing 200 p,g of LPS/animal. As shown in Fig. 4, skin tests performed 2 wk
after sensitization revealed good delayed hypersensitivity responses in the two
untreated control groups which were comparable in magnitude for both immuni-
zation regimens. In contrast, guinea pigs pretreated with ABA-T in IFA failed to
develop ABA-specific responses irrespective ofwhetherCFA orIFA plus LPS had
been used for sensitization.
Passive Transfer of ABA-Specific Suppression with Lymphoid Cells from
Donors Pretrated with ABA-T in IFA . The capacity of ABA-T administered in
IFA in moderate doses to result in markedly diminished responsiveness to
subsequent immunization with ABA-T in CFA suggests the possibility of an
active suppression phenomenon mediated by lymphoid cells. This possibility was
tested in a cell transfer experiment in the following manner: Inbred strain 13
guinea pigs were immunized with 50 ugofABA-T in CFA or injected with 50 Ag of
ABA-T in IFA. 3 wk later these respective donor groups were killed and their
axillary, occipital, inguinal, and popliteal lymph nodes and spleens removed.
Single cell suspensions, in minimum essential medium (Eagle's) were prepared,
washed, and transferred intravenously to unprimed, syngeneic recipients (400 x
108 cells/recipient). 1 wk after cell transfer these two groups and a third group of
control guinea pigswere skin tested with 60jug ABA-BSA. Positive skin reactions
were manifested only by the group that had received cells from donors
Group Immunization (wk0) ABA-HGG (50,ug,
wk 2)
MM
A 501ugABA-T(IFA) 2.3 (10.4)
B 50 Ag ABA-T(IFA + LPS) 19.7 (f0.9)
C 50 fagABA-T (CFA) 20.3 (11.2)
D 50 Wg ABA-T (CFA + LPS) 17.7 (10.9)WESLEY W . BULLOCK, DAVID H . KATZ, AND BARUJ BENACERRAF
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FIG. 4 .
￿
Two groups of guinea pigs were pretreated with 50 ug of ABA-T in IFA . 3 wk later
these animals and two groups of untreated controls were sensitized, respectively, with 50 ug
ofABA-T in either CFA or IFA containing 200Mg LPS/animal . Skin tests were performed2wk
later with 10 jug of ABA-HGG . The data are presented as the average reaction diameters in
millimeters of groups of five guinea pigs recorded 24 h after intradermal sensitization . The
vertical lines represent standard errors . The dashed line represents the mean reaction
diameters of nonsensitized control guinea pigs skin tested with the same preparation of
ABA-HGG at the same time . Statistical comparisons of the mean skin reactions of the
pretreated groups with those of the untreated controls yielded P values ofP < 0.001 in all
cases .
immunized with ABA-T in CFA (data not shown) . 1 day after skin tests all
animals were immunized with 50 Ag of ABA-T in CFA . 2 and 5 wk later all three
groups were tested for delayed sensitivity to ABA and PPD . At 2 wk both groups
of cell transfer receipients were partially suppressed in their responsiveness to
both ABA and PPD in comparison to the control group indicating some form of
nonspecific suppression . 5 wk after immunization (Fig . 5), however, it was clear
that recipients of cells from donors immunized with ABA-T in CFA responded to
ABA comparably to the control animals, whereas recipients of cells from donors
injected with ABA-T in IFA were markedly suppressed in this regard . Although
the magnitude ofPPD reactivity in the latter group was somewhat lower than the
other two groups, the difference was not significant .
Discussion
The studies presented in this paper demonstrate that the administration of
small-to-moderate doses of ABA-T in IFA to unprimed guinea pigs induces a
state of ABA-specific unresponsiveness as evidenced by the failure of animals so
treated to respond to immunization with ABA-T in CFA . The unresponsiveness
induced in this manner is persistent, indeed considerably more so than the
transient unresponsiveness induced by intravenous administration of large doses
ofABA-T as shown in earlier studies of Leskowitz and Collotti (15, 16) and in the
present studies . In previous studies, Loewi et al . were successful in inducing
tolerance to the mucopolysaccharide blood group substance A by administering
the latter in IFA to guinea pigs 2 wk before immunization with the substance in270
￿
T-CELL RESPONSES TO ABA-T . 11
FIG . 5 . Passive transfer of ABA-specific suppression with lymphoid cells from donors
pretreated with ABA-T in IFA . Inbred strain 13 guinea pigs were immunized with 50 FAg of
ABA-T in CFA or injected with 50Wg ofABA-T in IFA.3wk later these respective donor groups
were killed and their axillary, occipital, inguinal, and popliteal lymph nodes and spleens
removed . Single cell suspensions in minimum essential medium (Eagle's) were prepared,
washed, and transferred intravenously to unprimed, syngeneic recipients (400 x 10, cells/
recipient) . 1 wk after cell transfer, thesetwogroups (five recipients each) and a third group of
three control guinea pigs were skin tested with 60 leg ABA-BSA . 24 h later all animalswere
immunized in the foot pads with 50 kg ofABA-T in CFA. 2 and 5 wk later all three groups were
tested for delayed sensitivity toABA and PPD. The data presented are the average reaction
diameters in millimeters of the various groups recorded 24 h after skin testing with the test
antigens indicated at wk 5 after immunization . The vertical lines represent standard errors .
The dashed line represents the mean reaction diameters of nonsensitized control guinea pigs
skin tested with the same preparations of ABA-INS and PPD at the same time . Statistical
comparisons of the mean skin reactions of the two groups of cell transfer recipients with the
guinea pigs that did not receive cell transfers yielded the following P values for the two
skin-test antigens : (a) ABA-INS, P = 0.42and P = 0.0015 for recipients of CFA-primed and
IFA-primed cells, respectively ; (b) PPD, P = 0.49and P = 0.093 for recipients of CFA-primed
and IFA-primed cells, respectively . Statistical comparisons of the reactions of the two cell
transfer recipient groups yielded P values of 0.006 and 0.28 for ABA-INS and PPD,
respectively .
CFA (27) . The tolerance to ABA-T described in this paper is specific since T-cell
responses to PPD were not diminished by administering ABA-T in IFA before
subsequent sensitization with CFA.
The tolerant state induced by ABA-T in IFA has been shown to require
administration of ABA-T in the absence of bacterial adjuvant products . Thus,
incorporation of LPS into the IFA emulsion resulted in the development of
delayed hypersensitivity to ABA-T comparable in strength to that obtained with
ABA-T in CFA. The capacity ofLPS to have this effect is anotherdemonstration
of the strong adjuvant properties of this substance on T-lymphocyte functions .WESLEY W. BULLOCK, DAVID H. KATZ, AND BARUJ BENACERRAF
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Previous studies fromthis laboratory have demonstrated that LPS, in addition to
its mitogenic activity on B lymphocytes, is highly effective in regulating T-cell
functions such as the development and function of carrier-specific helper cells in
humoral responses (23-25) . The present studies show that LPS is capable of
regulating functions of T cells that are involved in development of delayed
hypersensitivity responses. Rcently, Nauciel et al. reportedthatwhole gram-neg-
ative bacteria, endotoxin, and purified cell wall peptidoglycan were all capable of
acting as adjuvant when added to ABA-acetyl-tyrosine IFA emulsions (28).
However, further study will be required to determine if both peptidoglycan and
LPS are effective adjuvants or whether minor contamination of LPS by
peptidoglycan is the cause of the observed LPS activity.
The possibility that the unresponsiveness resulting from ABA-T in IFA
reflected a phenomenon of active specific suppression was suggested by the fact
that in the present studiesonly relatively modest doses were required to induce a
rather persistent state of tolerance, and by the previous observations of Collotti
and Leskowitz (16) demonstrating that only ABA derivatives of immunogenic
carriers were capable of inducing ABA-specific tolerance. Indeed, the passive
transfer of lymph node and spleen cells from guinea pig donors pretreated with
ABA-T in IFA significantly suppressed the subsequent responses of unprimed
syngeneic recipients ofsuch cells to sensitization with ABA-T in CFA. Moreover,
in the accompanying manuscript, we will present evidence demonstrating that
animals rendered unresponsive by ABA-T in IFA possess ABA-specific suppres-
sor cells which are capable of suppressing delayed sensitivity responses to
determinants on proteins covalently linked to ABA (29). These findings,
although demonstrating the participation of active suppressor cells inthis model,
do not define the class of cell responsible for the suppression. We are assuming
that this suppression is mediated by specific T lymphocytes since the adminis-
tration of ABA-T generally fails to induce ABA-specific B-cell responses (9-12).
On the other hand, the recent indication of the participation of "suppressor" B
cells in other studies performed in guinea pigs (30, 31) leaves this an open
possibility in the ABA system that will require further delineation.
It is pertinent that the capacity ofABA-specific suppressor cells to induce and
maintain a state of unresponsiveness could only be demonstrated in unprimed
animals and likewise that the unresponsive state wasnotreversed by administra-
tion of ABA-T in the presence of LPS. Both of these observations point to the
likelihood that the cellular locus of suppression may well be that T lymphocyte
that will perform a helper function in the generation of ABA-specific effector T
cells. This reasoning follows from the assumption that if ABA-specific suppres-
sion were mediated directly on the mature effector cells, then one would expect to
observe suppression in either the inductive or elicitation phases of subsequent
immunization and skin testing of previously primed animals by administering
ABA-T in IFA. Such was not the case, however (Fig. 3). Moreover, since the
adjuvant properties of LPS and similar agents appear to exert most of their
effects on functions of helper or regulator T lymphocytes (23-27), the failure of
LPS to reverse unresponsiveness in this system is expected if thesuppressor cells
were acting to inhibit or diminish the numbers and/or activity of such helper T
cells. This is precisely what was observed in these studies (Fig. 4).272
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Further delineation of this point is extremely important in view of the critical
impact this might have on the therapeutic potential of such models of immune
suppression. If this specific suppression has little capacity to regulate the
responses of fully mature, primed effector cells, the clinical usefulness of this
approach would be severely limited.
Summary
The experiments presented in this paper demonstrate that the induction of
tolerance on the one hand and the induction of delayed sensitivity on the other
hand can be accomplished by administration of similar doses of azobenzene-ar-
sonate conjugated to N-chloroacetyl tyrosine (ABA-T) to guinea pigs with the
determining factor being the absence or presence, respectively, of activating bac-
terial products in the adjuvant mixture used. Thus, complete, persistent ABA-T-
specific T-cell tolerance can be induced in adult guinea pigs with 20 pg of ABA-T
given intradermally in incomplete Freund's adjuvant (IFA) whereas this same
dose of ABA-T induces ABA-specific immunity when administered in complete
Freund's adjuvant. This tolerance was not reversible by administration of ABA-T
and IFA in the presence of bacterial lipopolysaccharide, was generated before the
formation of primed T cells, and persisted for at least 3 mo after initiation.
Morover, cell transfer studies performed herein demonstrate that the unrespon-
siveness resulting from administration of ABA-T in IFA reflects the activity of
ABA-specific suppressor cells. The findings that the capacity of ABA-specific
suppressor cells to induce and maintain a state of unresponsiveness could only be
demonstrated in unprimed animals may indicate a severe limitation on the
potential clinical usefulness of such an approach to regulation of the immune
system.
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